CommercialCoverageMedium impact
Drug Policy Criteria Change
Arkansas Blue Cross Blue Shield·Psychiatry, Neurology, Family Medicine +2 more·Pharmacy
Effective date
May 17, 2026
We identified it
Jun 19, 2026
Summary
Three new FDA-approved medications have been added to drug formularies and criteria lists: Relgaabi (gabapentin) added to formulary, and Atoncy (ADHD agent) added to criteria and target drug lists across multiple plan types including Standard, Complete, Essential, and Metallic tiers.
Action Required
By May 17, 2026: Billing team must update pharmacy benefit systems and prior authorization protocols to recognize newly approved drugs Relgaabi (gabapentin) and Atoncy (ADHD agent) for Standard, Complete, Essential, and Metallic plan formularies. Verify coverage eligibility before prescribing these medications to avoid claim denials.